Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2002-01-10
2009-02-10
Kemmerer, Elizabeth C. (Department: 1649)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S007600, C514S008100, C514S012200
Reexamination Certificate
active
07488710
ABSTRACT:
This disclosure relates to a peptide motif and proteins containing the motif that are capable of binding to secreted Frizzled-related protein family members. Accordingly, the disclosure also includes methods of regulating the interaction of sFRP-1 with proteins containing the motif.
REFERENCES:
patent: 5204328 (1993-04-01), Nutt et al.
patent: 5238839 (1993-08-01), Cantor et al.
patent: 5352667 (1994-10-01), Lider et al.
patent: 5519005 (1996-05-01), Lider et al.
patent: 5536814 (1996-07-01), Ruoslahti et al.
patent: 5578569 (1996-11-01), Tam
patent: 5846932 (1998-12-01), Lowe et al.
patent: 5851984 (1998-12-01), Matthews et al.
patent: 5912234 (1999-06-01), Ruoslahti et al.
patent: 5939271 (1999-08-01), Tessier-Lavigne et al.
patent: 6043053 (2000-03-01), Barnes et al.
patent: 6110718 (2000-08-01), Shisheva
patent: 6479255 (2002-11-01), Rubin et al.
patent: 6589528 (2003-07-01), Ito et al.
patent: 6600018 (2003-07-01), Rubin et al.
patent: WO 97/39357 (1997-10-01), None
patent: WO 98/13493 (1998-04-01), None
patent: WO98/46751 (1998-10-01), None
patent: WO 98/54325 (1998-12-01), None
patent: WO 99/09152 (1999-02-01), None
patent: WO 99/26960 (1999-06-01), None
patent: WO 99/29865 (1999-06-01), None
patent: WO 01/19855 (2001-03-01), None
patent: WO 01/57188 (2001-08-01), None
Wells, 1990, Biochemistry 29:8509-8517.
Ngo et al., 1994, The Protein Folding Problem and Tertiary Structure Prediction, pp. 492-495.
Bork, 2000, Genome Research 10:398-400.
Skolnick et al., 2000, Trends in Biotech. 18(1):34-39.
Doerks et al., 1998, Trends in Genetics 14:248-250.
Smith et al., 1997, Nature Biotechnology 15:1222-1223.
Brenner, 1999, Trends in Genetics 15:132-133.
Bork et al., 1996, Trends in Genetics 12:425-427.
Garcia-Hoyos et al. Mol Vision 224; 10: 426-431.
EMBL Database, Jan. 25, 2000, Accession No. AF218056.
EMBL Database, Nov. 5, 1999, Accession No. AV354083.
EMBL Database, Nov. 3, 1999, Accession No. AV304328.
EMBL Database, Oct. 18, 1996, Accession No. U24163.
EMBL Database, Apr. 9, 1999, Accession No. AI587049.
Abu-Jawdeh, et al., “Differential expression of frpHE: a novel human stromal protein of the secreted frizzled gene family, during the endometrial cycle and malignancy,”Lab Invest. 79:439-447, 1999.
Ackerman and Knowles, “Cloning and mapping of theUNC5Cgene to human chromosome 4q21-123,”Genomics52:205-208, 1998.
Bafico, et al., “Interaction of frizzled related protein (FRP) with Wnt ligands and the frizzled receptor suggests alternative mechanisms for FRP inhibition of Wnt signaling,”J. Biol. Chem. 274:16180-16187, 1999.
Banyai, et al., “The NTR module: domains of netrins, secreted frizzled related proteins, and type 1 procollagen C-proteinase enhancer protein are homologous with tissue inhibitors of metalloproteases,”Protein Science8:1636-1642, 1999.
Baranski, et al., “The dynamic expression pattern offrzb-1suggests multiple roles in chick development,”Developmental Biology217:25-41, 2000.
Bhanot, et al., “A New Member of the Frizzled Family from Drosophila Functions as a Wingless Receptor,”Nature, 382(6588):225-230, Jul. 18, 1996.
Bradley and Brown, “The proto-oncogeneint-1 encodes a secreted protein associated with the extracellular matrix,”The EMBO Journal9(5):1569-1575, 1990.
Cadigan, et al., “Wnt Signaling: A Common Theme in Animal Development,”Genes&Development, 11(24):3286-3305, Dec. 15, 1997.
Chakrabarti, et al., “Secretory and inductive properties ofDrosophila winglessprotein inXenopusoocytes and embryos,”Development115(1):355-369, 1992.
Chan, et al., “Two homologs of theDrosophilapolarity gene frizzled (fz) are widely expressed in mammalian tissues,”The Journal of Biological Chemistry267(35):25202-25207, 1992.
Chang, et al., “Cloning and characterization of a secreted frizzled-related protein that is expressed by the retinal pigment epithelium,”Hum. Mol. Genet. 8:575-583, 1999.
Cole, et al., “Deciphering the biology of mycobacterium tuberculosis from the complete genome sequences,”Nature393:537-544, 1998.
Dale, “Signal transduction by the Wnt family of ligands,”Biochem. J. 329:209-223, 1998.
De Bellis, et al., “Thetbf-1 gene from the white truffletuber borchiicodes for a structural cell wall protein specifically expressed in fruitbody,”Fungal Genetics and Biology25:87-99, 1998.
Finch, et al., “Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth,”Science245:752-755, 1989.
Finch, et al., “Purification and Molecular Cloning of a Secreted, Frizzled-Related Antagonist of Wnt Action,”Proc. Natl. Acad. Sci., 94(13):6770-6775, Jun. 24, 1997.
Forcier, et al., “Characteristics of ANP-binding sites in the adrenal capsules of term-pregnant rats,”Molecular and Cellular Endocrinology117:189-194, 1996.
Fujiwara, et al., Otsuka cDNA Project, EMBL Database, Sep. 29, 1996, Accession No. C15983.
Gammelin, et al., “Two Subtypes of Nucleoproteins (NP) of Influenza A Viruses,”Virology170:71-80, 1989.
Gaynor, et al., “Peptide inhibition of glomerular deposition of an anti-DNA antibody,”Proc. Natl. Acad. Sci. USA94:1955-1960, 1997.
Hausler, et al., “Secreted frizzled-related proteins are expressed by osteoblasts,”Bone(New York) 27, p. 33S, 2000.
Hautanen, et al., “Effects of modifications of the RGD sequence and its context on recognition by the fibronectin receptor,”The Journal of Biological Chemistry264:1437-1442, 1989.
He, et al., “Glycogen synthase kinase-3 and dorsoventral patterning inXenopusembryos,”Nature374:617-622, 1995.
He, et al., “A Member of the Frizzled Protein Family Mediating Axis Induction by Wnt-5A,”Science, 275:1652-1654, Mar. 14, 1997.
Hedgecock, et al., “Netrins evoke mixed reactions in motile cells,”TIG13:251-253, 1997.
Hillier, “Soares-NhHMPu-S1 Homosapiens cDNA clone IMAGE:767205 SmRNA sequence,” Washu-Merck EST Project, Database EST, May 15, 1997, GenBank Accession No. AA424647.
Hillier, et al., Washu-Merck EST Project, EMBL Database, Apr. 5, 1996, Accession No. N75803, XP-00207764.
Hoang, et al., “Primary Structure and Tissue Distribution of FRZB, a Novel Protein Related to Drosphila Frizzled, Suggest a Role in Skeletal Morphogenesis,”The Journal of Biological Chemistry, 271(42):26131-26137, Oct. 18, 1996.
Hsieh, et al., “Biochemical characterization of Wnt-frizzled interactions using a soluble, biologically active vertebrate Wnt protein,”Proc. Natl. Acad. Sci. USA96:3546-3551, 1999.
Karavanova, et al., “Conditioned medium from a rat ureteric bud cell line in combination with bFGF induces complete differentiation of isolated metanephric mesenchyme,”Development122:4159-4167, 1996.
Kelley, et al., “Emergence of the keratinocyte growth factor multigene family during the great ape radiation,”Proc. Natl. Acad. Sci. USA89:9287-9291, 1992.
Korinek, et al., “Constitutive transcriptional activation by a β-catenin-Tcf complex in APC-/-colon carcinoma,”Science275:1784-1787, 1997.
Lalau, et al., “Natriuretic and Vasoactive Hormones and Glomerular Hyperfiltration in Hyperglycaemic Type 2 Diabetic Patients: Effect of Insulin Treatment,”Nephron63:296-302, 1993.
Leyns, et al., “Frzb-1 is a Secreted Antagonist of wnt Signaling Expressed in the Spemann Organizer,”Cell88(6):747-756, Mar. 21, 1997.
Lin, et al., “The cysteine-rich frizzled domain of Frzb-1 is required and sufficient for modulation of Wnt signaling,”Proc. Natl. Acad. Sci USA94:11196-11200, 1997.
Lowman, et al., “Molecular mimics of insulin-like growth factor 1 (IGF-1) for inhibiting IGF-1: IGF-binding protein interactions,”Biochemistry37:8870-8878, 1998.
Mayr, et al., “Fritz: a secreted frizzled-related protein that inhibits Wnt activity,”Mech. Dev. 63:109-125, 1997.
McMahon, “T
Gillespie Matthew Todd
Horwood Nicole Joy
Rubin Jeffrey S.
Üren Aykut
Borgeest Christina
Kemmerer Elizabeth C.
Klarquist & Sparkman, LLP
St. Vincent's Institute of Medical Research
The United States of America as represented by the Department of
LandOfFree
SFRP and peptide motifs that interact with SFRP and methods... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with SFRP and peptide motifs that interact with SFRP and methods..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and SFRP and peptide motifs that interact with SFRP and methods... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4084440